The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation
- *Department of Experimental Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105; ‡The Edward A. Doisey Department of Biochemistry, St. Louis University School of Medicine, St. Louis, MO 63104; and §Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110
-
Communicated by Peter C. Nowell, University of Pennsylvania School of Medicine, Philadelphia, PA (received for review October 28, 1999)
Abstract
Several lines of evidence suggest that the mixed lineage leukemia protein (MLL, ALL-1, HRX) plays a role in regulating myelomonocytic differentiation. In this study we examined the effect of expression of MLL-AF9 on differentiation of the monoblastic U937 cell line by using a tetracycline-inducible expression system. MLL-AF9 arrested growth of U937 cells and induced these cells to differentiate into macrophages; induction was accompanied by expression of CD11b and CD14 and ultimately cell death. Deletion mutants of MLL-AF9 were used to map the sequences responsible for this effect. The amino-terminal half of MLL was sufficient for both cell cycle arrest and macrophage differentiation, whereas the carboxyl terminus of MLL or AF9 was found to be dispensable for this effect. Further deletions showed that a 35-kDa amino-terminal fragment spanning two AT hook motifs was sufficient for cell cycle arrest, up-regulation of p21Cip1 and p27Kip1, and partial differentiation toward macrophages. These findings suggest a possible role for the MLL AT hook-containing region in regulating myelomonocytic differentiation.
Footnotes
-
↵ † C.C. and A.S. contributed equally to this work.
-
↵ ¶ To whom reprint requests should be addressed at: Department of Pathology and Laboratory Medicine, 6 Founders Pavilion, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104. E-mail: jhess{at}mail.med.upenn.edu.
-
Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.040574897.
-
Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.040574897
- Abbreviations:
- MLL,
- mixed lineage leukemia protein;
- HMG,
- high mobility group
- Copyright © 2000, The National Academy of Sciences





